Mesothelioma Surgery With Immunotherapy Proves Effective in Study
An immunotherapy combination given before aggressive surgery has shown impressive effectiveness in extending survival for pleural mesothelioma patients in a recent phase II clinical trial at Baylor College of Medicine.
The combination of immune checkpoint inhibitors durvalumab and tremelimumab showed an ability to effectively alter the intratumoral immune system and make surgery more effective.
This randomized clinical trial compared the use of durvalumab alone – already shown to be effective in other cancers – to both the two-drug combination and to using no immunotherapy before mesothelioma surgery.
Clinica...
Source: Asbestos and Mesothelioma News - December 19, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Pleural Source Type: news
Final Exams Don't Have to Be High Stress for Your Teen
SUNDAY, Dec. 18, 2022 -- Final exams are stressful for students, but it is possible to ratchet down the pressure with some planning and self-compassion.
A psychologist from Baylor College of Medicine in Houston offers a few suggestions for helping... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 18, 2022 Category: General Medicine Source Type: news
How Gene Editing Could Help Solve the Problem of Poor Cholesterol
Cardiovascular disease is the leading cause of death in the U.S. and around the world. Though it’s held the top spot for decades, it wasn’t always the king of mortal maladies. Its ascension was propelled by two of medical science’s greatest successes.
“Before the 20th century, heart disease was an uncommon cause of death,” says Dr. Michael Shapiro, a professor of cardiology at the Wake Forest University School of Medicine. Bacterial infections such as tuberculosis and dysentery, as well as smallpox and other contagious viruses, were common killers. “Antibiotics and vaccines changed every...
Source: TIME: Health - December 6, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate heart health Source Type: news
All the Flavor, Better Health: Holiday Dinner Ingredient Swaps That Work
WEDNESDAY, Nov. 23, 2022 -- Holiday meals offer an opportunity to indulge in some favorite foods.
Now for those who want to enjoy healthier versions of these holiday treats, a registered dietitian from Baylor College of Medicine in Houston offers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 23, 2022 Category: General Medicine Source Type: news
Vision Is Vulnerable With Age: Here's What to Look For
SUNDAY, Nov. 6, 2022 -- Routine eye checks can help ensure seniors know if they ' re developing any age-related vision issues.
An expert from Baylor College of Medicine spells out what seniors need to know. " Don ' t blame vision issues on just aging... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 6, 2022 Category: General Medicine Source Type: news
' Drug factory' implants eliminate mesothelioma tumors in mice
Researchers at Rice University and Baylor College of Medicine have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice ' s cytokine " drug factory " implants and a checkpoint inhibitor … (Source: NSF News)
Source: NSF News - October 19, 2022 Category: Science Authors: NSF Source Type: news
Obesity should be considered a brain disorder like autism or ADHD, US doctors sensationally claim
Researchers from Baylor College of Medicine in Texas have made the recommendation after a study indicated obesity was caused by changes in the brain during childhood. (Source: the Mail online | Health)
Source: the Mail online | Health - September 29, 2022 Category: Consumer Health News Source Type: news
UAMS Fellow Chosen for Fellowship Backed by NASA (Movers & Shakers)
Ashley Nemec-Bakk is one of three researchers nationwide chosen for the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - September 12, 2022 Category: American Health Source Type: news
Study: ‘ Drug-Factory ’ Technology Kills Mesothelioma Tumor Cells in Mice
Tiny, drug-producing beads implanted in the chest cavity could one day provide a powerful platform that would change the way mesothelioma cancer is treated.
In a recent study, researchers from Rice University and the Baylor College of Medicine demonstrated the implants’ impressive effectiveness in mice, raising hopes of a possible breakthrough for this tough-to-treat cancer.
Researchers have already met with the U.S. Food and Drug Administration, and hope to open a clinical trial to begin testing the procedure’s effectiveness on mesothelioma patients by the second half of 2023. Clinical Cancer Research publis...
Source: Asbestos and Mesothelioma News - August 30, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news
Peritoneal Dialysis Less Costly for Medicare Than Hemodialysis
WEDNESDAY, Aug. 24, 2022 -- Peritoneal dialysis (PD) costs Medicare less than hemodialysis, according to a study published online Aug. 18 in the Journal of the American Society of Nephrology.
Jennifer M. Kaplan, M.D., from Baylor College of Medicine... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2022 Category: Pharmaceuticals Source Type: news
Dying Patients Are Fighting for Access to Psychedelics
Erinn Baldeschwiler, a 48-year-old with metastatic breast cancer, is struggling with anxiety and depression as she nears the untimely end of her life. “The last thing I want is to be terrified and scared and anxious, especially when I pass,” she says.
She knows that no treatment can change the outcome of her disease. But she’s fighting for access to a different kind of therapeutic: psilocybin-assisted therapy, which past research has found can ease anxiety for depression in advanced cancer patients.
Psilocybin (the active ingredient in magic mushrooms) and other potentially life-changing psychedelic drug...
Source: TIME: Health - August 24, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Up Your Skin Care Routine During Hot Summer Months
SATURDAY, Aug. 13, 2022 -- Sweating can affect your skin, so learning how to handle it should be an important part of your skin care regime, a Baylor College of Medicine aesthetician says. " Sweating is an important bodily function that cools you... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2022 Category: General Medicine Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Investor Update - August 12, 2022 Category: Pharmaceuticals Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news
As the Virus Evolves, COVID-19 Reinfections Are Going to Keep Happening
After the Omicron variant caused massive numbers of infections this past winter, lots of people looked on the bright side, hoping it would be “a free shot for the country,” says Eli Rosenberg, deputy director for science at the New York State Department of Health’s Office of Public Health. Even though lots of people got infected with the highly contagious variant, at least they would then have immunity against the virus, protecting them from getting sick in the future. In theory.
But that hasn’t turned out to be true. Many people—even those who are vaccinated, boosted, and previously infected&...
Source: TIME: Health - May 18, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
